8.9K views · 150 reactions | By using messenger ribonucleic acid (or mRNA) as a platform for delivering vaccinations, biotech companies like Moderna, Inc. have been able to rewrite COVID vaccines swiftly to address newly-emergent variant strains. https://cbsn.ws/3vB4Syh | CBS Sunday Morning | Facebook

After the federal government called off around $500 million of vaccine development projects that use mRNA technology, Dr. William Schaffner of Vanderbilt University explains why the technology is not "new," and what could be lost ahead of a potential next pandemic. https://www.cbsnews.com/news/rfk-jr-halts-500-million-for-mrna-vaccine-research/ | CBS News